33 results on '"Sugarman, Barry J"'
Search Results
2. Recombinant Human PH20: Baseline Analysis of the Reactive Antibody Prevalence in the General Population Using Healthy Subjects
3. Video--post- vehicle tumor vascular area from Enzymatic Depletion of Tumor Hyaluronan Induces Antitumor Responses in Preclinical Animal Models
4. Video Legend from Enzymatic Depletion of Tumor Hyaluronan Induces Antitumor Responses in Preclinical Animal Models
5. Video--post- PEGPH20 tumor vascular area from Enzymatic Depletion of Tumor Hyaluronan Induces Antitumor Responses in Preclinical Animal Models
6. Tolerability and Pharmacokinetic Properties of Ondansetron Administered Subcutaneously With Recombinant Human Hyaluronidase in Minipigs and Healthy Volunteers
7. Clinical Immunogenicity of rHuPH20, a Hyaluronidase Enabling Subcutaneous Drug Administration
8. Tumor Necrosis Factor: A Potent Effector Molecule for Tumor Cell Killing by Activated Macrophages
9. Dispersive effects and focused biodistribution of recombinant human hyaluronidase PH20: A locally acting and transiently active permeation enhancer
10. Erratum to: Clinical Immunogenicity of rHuPH20, a Hyaluronidase Enabling Subcutaneous Drug Administration
11. Interferon α2b gene delivery using adenoviral vector causes inhibition of tumor growth in xenograft models from a variety of cancers
12. A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Hyaluronidase PH20 Administered Intravenously in Healthy Volunteers
13. Recombinant Human Tumor Necrosis Factor-$\alpha $: Effects on Proliferation of Normal and Transformed Cells in vitro
14. Interferon-α2b Secretion by Adenovirus-Mediated Gene Delivery in Rat, Rabbit, and Chimpanzee Results in Similar Pharmacokinetic Profiles
15. KIAA1199 expression and hyaluronan degradation colocalize in multiple sclerosis lesions
16. PH20 is not expressed in murine CNS and oligodendrocyte precursor cells
17. Abstract 3375: Phase 1 pharmacodyamic activity of multiple-dose PEGylated hyaluronidase PH20 (PEGPH20) in patients with solid tumors.
18. Abstract 2672: Phase 1 pharmacokinetics (PK) & pharmacodynamics (PD) of PEGylated hyaluronidase PH20 (PEGPH20) in patients with solid tumors
19. Enzymatic Depletion of Tumor Hyaluronan Induces Antitumor Responses in Preclinical Animal Models
20. Accelerated Pharmacokinetics and Glucodynamics of Prandial Insulins Injected With Recombinant Human Hyaluronidase
21. 572. rAd-p21 To Reduce Excessive Dermal Scarring: Efficacy, Expression, and Tensile Strength in Animal Models
22. Tumor Growth Inhibition by Interferon-α using PEGylated Protein or Adenovirus Gene Transfer with Constitutive or Regulated Expression
23. Enhanced Apoptotic Activity of a p53 Variant in Tumors Resistant to Wild-Type p53 Treatment
24. Selective Expression of Nonsecreted Interferon by an Adenoviral Vector Confers Antiproliferative and Antiviral Properties and Causes Reduction of Tumor Growth in Nude Mice
25. Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro
26. In Vivo Tumor Suppression by Adenovirus-Mediated Interferon alpha2b Gene Delivery
27. Analytical Anion-Exchange HPLC of Recombinant Type-5 Adenoviral Particles
28. Purification of a Type 5 Recombinant Adenovirus Encoding Human p53 by Column Chromatography
29. Synergistic induction of polypeptides by tumor necrosis factor and interferon‐gamma in cells sensitive or resistant to tumor necrosis factor: Assessment by computer based analysis of two‐dimensional gels using the PDQUEST system
30. A chicken histone H3 gene contains intervening sequences.
31. Chromosomal arrangement of the chicken β-type globin genes
32. Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in Vitro
33. Tumor growth inhibition by interferon-alpha using PEGylated protein or adenovirus gene transfer with constitutive or regulated expression.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.